about
Role of p-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer--a prospective clinical studyPrognostic imaging in neoadjuvant chemotherapy of locally-advanced breast cancer should be cost-effectiveEvaluating the response of neoadjuvant chemotherapy for treatment of breast cancer: are tumor biomarkers and dynamic contrast enhanced MR images useful predictive tools?Prediction of pathological complete response of breast cancer patients undergoing neoadjuvant chemotherapy: usefulness of breast MRI computer-aided detectionTopoisomerase II alpha and TLE3 as predictive markers of response to anthracycline and taxane-containing regimens for neoadjuvant chemotherapy in breast cancer.Impact of neoadjuvant chemotherapy on breast reconstructionSentinel lymph node biopsy alone after neoadjuvant chemotherapy in patients with initial cytology-proven axillary node metastasisContraindications of sentinel lymph node biopsy: are there any really?Effect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: A meta-analysis.Efficacy of vinorelbine-based neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis of randomized controlled trials.Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients, including those with axillary lymph node metastases confirmed by fineNeoadjuvant systemic therapy for breast cancer: an overview and review of recent clinical trials.Axillary recurrence after a tumor-positive sentinel lymph node biopsy without axillary treatment: a review of the literatureHistologic Grade and Decrease in Tumor Dimensions Affect Axillary Lymph Node Status after Neoadjuvant Chemotherapy in Breast Cancer PatientsContrast-enhanced US and MRI for assessing the response of breast cancer to neoadjuvant chemotherapy().Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer.Correlation between the molecular subtype of breast cancer and the in vitro adenosine triphosphate-based chemosensitivity assay.Evaluation of clinical and pathological response after two cycles of neoadjuvant chemotherapy on Sudanese patients with locally advanced breast cancer.Neoadjuvant Chemotherapy Creates Surgery Opportunities For Inoperable Locally Advanced Breast Cancer.Residual Mammographic Microcalcifications and Enhancing Lesions on MRI After Neoadjuvant Systemic Chemotherapy for Locally Advanced Breast Cancer: Correlation with Histopathologic Residual Tumor Size.Shear-Wave Elastography for the Detection of Residual Breast Cancer After Neoadjuvant Chemotherapy.Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis.Clinical and Pathological Response to Neoadjuvant Anthracycline Based Chemotherapy in women with breast cancer.The role of radioactive iodine-125 seed localization in breast-conserving therapy following neoadjuvant chemotherapy.Predictive and prognostic significance of cytoplasmic expression of ELAV-like protein HuR in invasive breast cancer treated with neoadjuvant chemotherapy.Impact of patient demographics, tumor characteristics, and treatment type on treatment delay throughout breast cancer care at a diverse academic medical center.Neoadjuvant chemotherapy increases the rate of breast conservation in lobular-type breast cancer patients.Study on predictive role of AR and EGFR family genes with response to neoadjuvant chemotherapy in locally advanced breast cancer in Indian women.
P2860
Q24815650-8CE877E2-F182-42F6-9797-FB25C943818EQ33593185-672B37DB-2265-4FD3-9B00-905BE9217753Q33814616-3ADB84FF-01A9-42C4-BAD0-FFD91543FD42Q34392087-46146BC7-9BBD-46D0-ACDB-E1DC60AAE429Q34555411-A74CEF7D-037E-443F-96A4-D0538FE2ACF5Q35190289-C2391056-F5D0-47B7-AA34-3A9F93ECAAD2Q35237199-FE4D1C9F-72AA-4FAC-BF47-061334556FD1Q35634145-EEE451F5-4089-42AA-9C17-99CEE930AF1AQ35759050-FB14798C-8A5F-4324-881A-6AAF92638047Q35954081-9AB36AEF-EC30-411F-A0D1-9508FF9493A1Q36166625-72C4A728-C95D-4619-A4F3-0C6C57648DE5Q36221963-7BDA25A5-207D-4D2C-BF4C-4359AF201BF2Q36420776-9106FB91-13F4-4422-B683-21C5077DC330Q36441562-80A8F23F-3EBF-44BB-86BD-A865F51B32DBQ36556783-CBC94563-393C-4F4D-9480-4D5A4F0304C4Q36787344-2491F9C8-7D5C-48F3-8775-5E9A2380FA9BQ36897666-31B8DEA2-5563-443C-BEA9-900A754473C3Q37594471-C2FDB58F-20C2-4D6A-87D0-FD56675DD495Q37714871-A2E3FF02-5A21-468A-A2F5-99591E8DD9BEQ38420000-0B60CC70-B4F4-418D-9EBF-3F4FA85B918DQ38423166-D41E377F-5177-4521-B970-6A6DBAE82754Q44382397-49E00380-00A7-420F-BE4A-F348CA4B5941Q45352880-3114560B-008F-481E-8A9A-4EA3379B6F30Q45858975-97B35F74-4FAC-4C76-8814-E8344392E397Q45929654-4E44CD12-F72F-457B-9DDF-102F62EB6DA7Q47106454-6F160403-9A37-44F0-AEF3-BB25D76B34B9Q51021864-A01CBD7D-031C-4ADE-82D4-80696DB8F564Q54375700-9B022371-8A32-405A-8FE5-B7494791F25E
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Neoadjuvant chemotherapy in breast cancer.
@ast
Neoadjuvant chemotherapy in breast cancer.
@en
type
label
Neoadjuvant chemotherapy in breast cancer.
@ast
Neoadjuvant chemotherapy in breast cancer.
@en
prefLabel
Neoadjuvant chemotherapy in breast cancer.
@ast
Neoadjuvant chemotherapy in breast cancer.
@en
P2093
P2860
P356
P1476
Neoadjuvant chemotherapy in breast cancer.
@en
P2093
Charfare H
Limongelli S
Purushotham AD
P2860
P356
10.1002/BJS.4840
P407
P577
2005-01-01T00:00:00Z